
Oncology NEWS International
- Oncology NEWS International Vol 5 No 8
- Volume 5
- Issue 8
NCI Says Long-Awaited Long Island Breast Cancer Study Now Underway
BETHESDA, Md--The Long Island Breast Cancer Study Project, ordered by Congress in 1993, is now underway under the auspices of the NCI and the National Institute of Environmental Health Sciences. The study will attempt to determine whether pollutants (pesticides and other chemical irritants) are linked to the area's excessive breast cancer rates.
BETHESDA, Md--The Long Island Breast Cancer Study Project, orderedby Congress in 1993, is now underway under the auspices of theNCI and the National Institute of Environmental Health Sciences.The study will attempt to determine whether pollutants (pesticidesand other chemical irritants) are linked to the area's excessivebreast cancer rates.
During, the 4-year study, being conducted by researchers fromColumbia University School of Public Health, 33 Long Island hospitalswill provide the names of newly diagnosed breast cancer patientswhom the researchers will invite to join the study. Blood andurine samples will be taken prior to treatment, along with a familyand medical history. The researchers will collect dust, water,and soil samples from the homes of 325 participants. Planned enrollmentis 1,600 patients plus 1,600 controls, with results expected by1999.
Articles in this issue
almost 30 years ago
Chemo Improves Pain Relief in Advanced Prostate Canceralmost 30 years ago
NCCR Urges Congress to Support Senate Bill for Cancer Researchalmost 30 years ago
Researchers Propose New Treatment Guidelines for HIValmost 30 years ago
Salvage Cryotherapy for Prostate Cancer Studied at M.D. Andersonalmost 30 years ago
FNA Dropped From RDOG Study Due To High Rate of Insufficient Samplesalmost 30 years ago
New Thinking on HIV Progression Leads to New Strategiesalmost 30 years ago
Hospitals Told Not to Capitate for 'Wrong' Reasonsalmost 30 years ago
More Study Needed of Possible Carcinogenesis of Winter Gas Additivealmost 30 years ago
President Makes NCAB AppointmentsNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Related Content


122 Adjuvant Ribociclib (RIB) Plus Nonsteroidal Aromatase Inhibitor (NSAI) in Patients With HR+/HER2− Early Breast Cancer (EBC): NATALEE 5-Year Outcomes




















































